Exozymes Inc. (EXOZ) is the 292nd largest of 300 Specialty Chemicals companies by market capitalisation, at 53.43 Mn, behind Zentek Ltd. at 60.36 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GLW | Corning Inc /Ny | primary | M-02 | Chemicals | MG-01 | 145.18 Bn | 70.00 | 8.56 | 142.67 Bn |
| 2 | ATI | Ati Inc | primary | M-02 | Chemicals | MG-01 | 28.28 Bn | 57.85 | 6.00 | 27.50 Bn |
| 3 | Q | Qnity Electronics, Inc. | primary | M-02 | Chemicals | MG-01 | 26.28 Bn | 43.30 | 5.04 | 25.32 Bn |
| 4 | IFF | International Flavors & Fragrances Inc | primary | M-02 | Chemicals | MG-01 | 21.50 Bn | 73.64 | 2.15 | 20.93 Bn |
| 5 | DD | DuPont de Nemours, Inc. | primary | M-02 | Chemicals | MG-01 | 17.40 Bn | 94.03 | 2.49 | 15.66 Bn |
| 6 | AVY | Avery Dennison Corp | primary | M-02 | Chemicals | MG-01 | 12.97 Bn | 18.40 | 1.40 | 12.74 Bn |
| 7 | ESI | Element Solutions Inc | primary | M-02 | Chemicals | MG-01 | 8.73 Bn | 48.84 | 2.77 | 8.54 Bn |
| 8 | EMN | Eastman Chemical Co | primary | M-02 | Chemicals | MG-01 | 7.82 Bn | 11.71 | 0.88 | 7.13 Bn |
| 9 | HXL | Hexcel Corp /De/ | primary | M-02 | Chemicals | MG-01 | 6.84 Bn | 44.58 | 3.46 | 6.78 Bn |
| 10 | SXT | Sensient Technologies Corp | primary | M-02 | Chemicals | MG-01 | 5.60 Bn | 36.05 | 3.29 | 5.57 Bn |
| 11 | BCPC | Balchem Corp | primary | M-02 | Chemicals | MG-01 | 5.37 Bn | 32.63 | 4.94 | 5.30 Bn |
| 12 | CLMT | Calumet, Inc. /DE | primary | M-02 | Chemicals | MG-01 | 4.90 Bn | -35.81 | 1.07 | 4.75 Bn |
| 13 | CBT | Cabot Corp | primary | M-02 | Chemicals | MG-01 | 4.15 Bn | 18.79 | 1.14 | 3.90 Bn |
| 14 | ASH | Ashland Inc. | primary | M-02 | Chemicals | MG-01 | 3.30 Bn | 14.35 | 1.79 | 2.86 Bn |
| 15 | KWR | Quaker Chemical Corp | primary | M-02 | Chemicals | MG-01 | 2.67 Bn | 33.19 | 1.35 | 2.52 Bn |
| 16 | HWKN | Hawkins Inc | primary | M-02 | Chemicals | MG-01 | 2.60 Bn | 32.31 | 2.35 | 2.60 Bn |
| 17 | NGVT | Ingevity Corp | primary | M-02 | Chemicals | MG-01 | 2.36 Bn | 43.72 | 2.03 | 2.18 Bn |
| 18 | ROG | Rogers Corp | primary | M-02 | Chemicals | MG-01 | 2.32 Bn | 74.12 | 2.78 | 2.11 Bn |
| 19 | IOSP | Innospec Inc. | primary | M-02 | Chemicals | MG-01 | 2.30 Bn | 20.06 | 1.25 | 2.05 Bn |
| 20 | SCL | Stepan Co | primary | M-02 | Chemicals | MG-01 | 1.41 Bn | -3,207.40 | 0.58 | 1.30 Bn |
| 21 | FTK | Flotek Industries Inc/Cn/ | primary | M-02 | Chemicals | MG-01 | 0.99 Bn | 26.18 | 3.40 | 0.99 Bn |
| 22 | KOP | Koppers Holdings Inc. | primary | M-02 | Chemicals | MG-01 | 0.88 Bn | -10.17 | 0.47 | 0.84 Bn |
| 23 | LWLG | Lightwave Logic, Inc. | primary | M-02 | Chemicals | MG-01 | 0.82 Bn | -65.48 | 5,683.13 | 0.82 Bn |
| 24 | MATV | Mativ Holdings, Inc. | primary | M-02 | Chemicals | MG-01 | 0.69 Bn | 7.68 | 0.35 | 0.62 Bn |
| 25 | RYAM | Rayonier Advanced Materials Inc. | primary | M-02 | Chemicals | MG-01 | 0.57 Bn | -4.25 | 0.39 | 0.52 Bn |
| 26 | ASPI | ASP Isotopes Inc. | primary | M-02 | Chemicals | MG-01 | 0.47 Bn | -3.16 | 15.25 | 0.22 Bn |
| 27 | MAGN | Magnera Corp | primary | M-02 | Chemicals | MG-01 | 0.42 Bn | -4.97 | 0.13 | 0.14 Bn |
| 28 | ASPN | Aspen Aerogels Inc | primary | M-02 | Chemicals | MG-01 | 0.40 Bn | -8.97 | 1.98 | 0.25 Bn |
| 29 | OEC | Orion S.A. | primary | M-02 | Chemicals | MG-01 | 0.32 Bn | -3.38 | 0.18 | 0.27 Bn |
| 30 | ALTO | Alto Ingredients, Inc. | primary | M-02 | Chemicals | MG-01 | 0.30 Bn | 5.96 | 0.32 | 0.27 Bn |
| 31 | FF | FutureFuel Corp. | primary | M-02 | Chemicals | MG-01 | 0.24 Bn | -8.18 | 1.55 | 0.20 Bn |
| 32 | HDSN | Hudson Technologies Inc /Ny | primary | M-02 | Chemicals | MG-01 | 0.22 Bn | 24.93 | 0.87 | 0.20 Bn |
| 33 | ACNT | Ascent Industries Co. | primary | M-02 | Chemicals | MG-01 | 0.14 Bn | -30.75 | 1.63 | 0.11 Bn |
| 34 | CITR | CitroTech Inc. | primary | M-02 | Chemicals | MG-01 | 0.11 Bn | -3.54 | 83.92 | 0.11 Bn |
| 35 | ARQ | Arq, Inc. | primary | M-02 | Chemicals | MG-01 | 0.09 Bn | -1.75 | 0.74 | 0.09 Bn |
| 36 | KBLB | Kraig Biocraft Laboratories, Inc. | primary | M-02 | Chemicals | MG-01 | 0.09 Bn | -22.78 | — | 0.09 Bn |
| 37 | NTIC | Northern Technologies International Corp | primary | M-02 | Chemicals | MG-01 | 0.07 Bn | -948.34 | 0.81 | 0.07 Bn |
| 38 | ZTEK | Zentek Ltd. | primary | M-02 | Chemicals | MG-01 | 0.06 Bn | -11.95 | 256.85 | 0.05 Bn |
| 39 | EXOZ | Exozymes Inc. | primary | M-02 | Chemicals | MG-01 | 0.05 Bn | -5.19 | — | 0.05 Bn |
| 40 | SCIA | SCI Engineered Materials, Inc. | primary | M-02 | Chemicals | MG-01 | 0.04 Bn | 14.80 | 1.33 | 0.03 Bn |
| 41 | NNUP | Nocopi Technologies Inc/Md/ | primary | M-02 | Chemicals | MG-01 | 0.02 Bn | -35.52 | 10.80 | 0.02 Bn |
| 42 | INM | InMed Pharmaceuticals Inc. | primary | M-02 | Chemicals | MG-01 | 0.01 Bn | -0.66 | — | 0.00 Bn |
| 43 | BON | Bon Natural Life Ltd | primary | M-02 | Chemicals | MG-01 | 0.00 Bn | -1.52 | 0.49 | -0.02 Bn |
| 44 | SMTK | SmartKem, Inc. | primary | M-02 | Chemicals | MG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 45 | TSEOQ | Trinseo PLC | primary | M-02 | Chemicals | MG-01 | 0.00 Bn | 0.00 | 0.00 | -0.18 Bn |
| 46 | CNEY | Cn Energy Group. Inc. | primary | M-02 | Chemicals | MG-01 | 0.00 Bn | -0.02 | 0.01 | -0.02 Bn |
| 47 | TANH | Tantech Holdings Ltd | primary | M-02 | Chemicals | MG-01 | 0.00 Bn | -0.01 | 0.00 | -0.03 Bn |
| 48 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 643.26 Bn | 30.58 | 6.57 | 622.50 Bn |
| 49 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 443.31 Bn | 70.19 | 6.89 | 436.74 Bn |
| 50 | CVX | Chevron Corp | secondary | E-01 | Oil and Gas Upstream | EG-01 | 421.06 Bn | 20.14 | 1.96 | 412.53 Bn |
| 51 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.74 Bn | 115.10 | 5.48 | 357.60 Bn |
| 52 | AMGN | Amgen Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 211.73 Bn | 24.22 | 5.56 | 197.74 Bn |
| 53 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 180.92 Bn | -62.49 | 5.94 | 177.74 Bn |
| 54 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.16 Bn | 30.00 | 10.50 | 124.30 Bn |
| 55 | PSX | Phillips 66 | secondary | E-01 | Oil and Gas Upstream | EG-01 | 104.71 Bn | 14.56 | 0.67 | 100.61 Bn |
| 56 | REGN | Regeneron Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 82.89 Bn | 19.15 | 5.34 | 74.90 Bn |
| 57 | SHW | Sherwin Williams Co | secondary | M-03 | Chemicals | MG-01 | 78.18 Bn | 29.08 | 3.20 | 77.89 Bn |
| 58 | ECL | Ecolab Inc. | secondary | I-38 | Environmental Equipment | IG-09 | 76.62 Bn | 37.32 | 4.55 | 71.48 Bn |
| 59 | HON | Honeywell International Inc | secondary | I-01 | Aerospace and Defense | IG-01 | 65.01 Bn | 8.00 | 1.71 | 55.81 Bn |
| 60 | ARGX | Argenx Se | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 61.41 Bn | 35.80 | 11.75 | 56.23 Bn |
| 61 | MRNA | Moderna, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 53.99 Bn | -17.13 | 24.23 | 48.85 Bn |
| 62 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.33 Bn | 11.23 | 0.98 | 44.95 Bn |
| 63 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.84 Bn | 61.56 | 2.47 | 39.19 Bn |
| 64 | LYB | LyondellBasell Industries N.V. | secondary | M-01 | Chemicals | MG-01 | 41.72 Bn | -120.91 | 1.34 | 39.09 Bn |
| 65 | ALNY | Alnylam Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 34.48 Bn | 44.51 | 7.18 | 31.18 Bn |
| 66 | BIIB | Biogen Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 31.15 Bn | 37.32 | 3.11 | 29.86 Bn |
| 67 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.05 Bn | -20.25 | 2,751.33 | 30.05 Bn |
| 68 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.99 Bn | -31.97 | 24.60 | 26.83 Bn |
| 69 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.23 Bn | 15.65 | 4.34 | 20.69 Bn |
| 70 | PPG | Ppg Industries Inc | secondary | M-03 | Chemicals | MG-01 | 23.95 Bn | 15.15 | 1.46 | 22.36 Bn |
| 71 | BNTX | BioNTech SE | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 23.72 Bn | -13.92 | 7.67 | 10.06 Bn |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 18.20 Bn | 21.48 | 2.14 | 17.79 Bn |
| 73 | MKSI | Mks Inc | secondary | T-03 | Semiconductors | TG-01 | 18.08 Bn | 74.11 | 4.16 | 17.47 Bn |
| 74 | MDGL | Madrigal Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 15.87 Bn | -49.74 | 12.36 | 15.03 Bn |
| 75 | ASND | Ascendis Pharma A/S | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 15.87 Bn | 18.30 | 11.19 | 14.92 Bn |
| 76 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.65 Bn | 22.19 | 4.64 | 15.26 Bn |
| 77 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.22 Bn | 16.17 | 3.31 | 13.60 Bn |
| 78 | FN | Fabrinet | secondary | T-14 | Computer Hardware | TG-02 | 14.94 Bn | 31.58 | 3.22 | 14.06 Bn |
| 79 | ALB | Albemarle Corp | secondary | M-11 | Metals and Mining | MG-02 | 14.91 Bn | 71.94 | 2.52 | 13.28 Bn |
| 80 | BBIO | BridgeBio Pharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 14.90 Bn | -21.53 | 20.89 | 14.18 Bn |
| 81 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.62 Bn | 16.98 | 6.00 | 13.78 Bn |
| 82 | SMMT | Summit Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 13.63 Bn | — | — | 12.94 Bn |
| 83 | RPM | Rpm International Inc/De/ | secondary | M-03 | Chemicals | MG-01 | 12.67 Bn | 19.13 | 1.61 | 12.36 Bn |
| 84 | HALO | Halozyme Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.58 Bn | 30.43 | 7.56 | 12.35 Bn |
| 85 | BMRN | Biomarin Pharmaceutical Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.45 Bn | 170.57 | 3.65 | 11.57 Bn |
| 86 | ARWR | Arrowhead Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 11.85 Bn | -43.53 | 17.69 | 10.24 Bn |
| 87 | AAVXF | Abivax S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.92 Bn | -25.97 | — | 10.92 Bn |
| 88 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.89 Bn | -70.84 | 14.02 | 10.57 Bn |
| 89 | APGE | Apogee Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.18 Bn | -34.62 | — | 9.20 Bn |
| 90 | GMED | Globus Medical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.11 Bn | 18.88 | 3.21 | 9.51 Bn |
| 91 | AVTR | Avantor, Inc. | secondary | I-31 | Distribution and Rental | IG-07 | 10.07 Bn | -17.42 | 1.53 | 9.76 Bn |
| 92 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.05 Bn | -26.35 | — | 9.29 Bn |
| 93 | RDY | Dr Reddys Laboratories Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.91 Bn | 785.46 | 2.70 | 9.74 Bn |
| 94 | PTGX | Protagonist Therapeutics, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.56 Bn | 86.62 | 33.92 | 9.56 Bn |
| 95 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.24 Bn | -43.52 | 10.57 | 7.18 Bn |
| 96 | WLK | Westlake Corp | secondary | M-01 | Chemicals | MG-01 | 9.21 Bn | -7.73 | 0.82 | 7.36 Bn |
| 97 | VIAV | Viavi Solutions Inc. | secondary | T-15 | Computer Hardware | TG-02 | 8.98 Bn | -287.90 | 5.92 | 8.33 Bn |
| 98 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.96 Bn | -47.63 | — | 8.96 Bn |
| 99 | PCVX | Vaxcyte, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.59 Bn | -8.13 | — | 8.59 Bn |
| 100 | IBRX | ImmunityBio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.47 Bn | -8.54 | 51.11 | 8.12 Bn |
| 101 | IMVT | Immunovant, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.97 Bn | -14.81 | — | 7.97 Bn |
| 102 | TWST | Twist Bioscience Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 7.86 Bn | -57.50 | 18.21 | 7.70 Bn |
| 103 | TGTX | Tg Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.77 Bn | 17.59 | 9.72 | 7.09 Bn |
| 104 | ICL | ICL Group Ltd. | secondary | M-04 | Chemicals | MG-01 | 7.61 Bn | 23.05 | 0.99 | 6.95 Bn |
| 105 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.46 | 9.09 Bn |
| 106 | SYRE | Spyre Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.38 Bn | -41.27 | — | 7.38 Bn |
| 107 | SRRK | Scholar Rock Holding Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.14 Bn | -17.69 | — | 7.14 Bn |
| 108 | SASOF | Sasol Ltd | secondary | E-01 | Oil and Gas Upstream | EG-01 | 7.01 Bn | 9.20 | 0.43 | 4.43 Bn |
| 109 | RYTM | Rhythm Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.93 Bn | -32.98 | 28.90 | 6.60 Bn |
| 110 | INGR | Ingredion Inc | secondary | S-07 | Agribusiness | SG-03 | 6.37 Bn | 10.64 | 0.88 | 5.42 Bn |
| 111 | CGON | CG Oncology, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.36 Bn | -28.39 | 1,021.85 | 6.36 Bn |
| 112 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.31 Bn | -704.68 | 4,533.84 | 6.31 Bn |
| 113 | MIRM | Mirum Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.25 Bn | -7.27 | 10.12 | 5.82 Bn |
| 114 | KNSA | Kiniksa Pharmaceuticals International, plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.09 Bn | 75.51 | 7.24 | 5.56 Bn |
| 115 | XENE | Xenon Pharmaceuticals Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.87 Bn | -16.20 | — | 5.87 Bn |
| 116 | COGT | Cogent Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.84 Bn | -15.79 | — | 5.84 Bn |
| 117 | DBVT | DBV Technologies S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.83 Bn | -33.11 | 1,160.93 | 5.65 Bn |
| 118 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.78 Bn | 29.31 | 19.90 | 4.42 Bn |
| 119 | ORKA | Oruka Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.74 Bn | — | — | 4.01 Bn |
| 120 | PTCT | Ptc Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.62 Bn | 14.70 | 5.57 | 3.39 Bn |
| 121 | MTRN | MATERION Corp | secondary | M-16 | Metals and Mining | MG-02 | 5.30 Bn | 58.78 | 2.52 | 5.28 Bn |
| 122 | PRM | Perimeter Solutions, Inc. | secondary | I-04 | Machinery | IG-02 | 5.11 Bn | -15.06 | 6.76 | 5.03 Bn |
| 123 | CELC | Celcuity Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.98 Bn | -22.73 | — | 4.98 Bn |
| 124 | CSW | Csw Industrials, Inc. | secondary | I-14 | Construction Products | IG-03 | 4.90 Bn | — | — | 4.87 Bn |
| 125 | CE | Celanese Corp | secondary | M-01 | Chemicals | MG-01 | 4.90 Bn | -4.24 | 0.50 | 3.54 Bn |
| 126 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.89 Bn | -17.03 | — | 4.89 Bn |
| 127 | AXTI | Axt Inc | secondary | T-04 | Semiconductors | TG-01 | 4.19 Bn | -2,771.63 | 35.93 | 3.40 Bn |
| 128 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.06 Bn | -7.94 | 1,126.80 | 4.06 Bn |
| 129 | DNTH | Dianthus Therapeutics, Inc. /DE/ | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.05 Bn | — | — | 3.64 Bn |
| 130 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -521.64 | 4.64 | 3.59 Bn |
| 131 | VKTX | Viking Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.83 Bn | -7.15 | — | 3.83 Bn |
| 132 | RLAY | Relay Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.80 Bn | -13.27 | 366.70 | 3.80 Bn |
| 133 | IOVA | Iovance Biotherapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.79 Bn | -18.13 | 11.66 | 3.49 Bn |
| 134 | AMLX | Amylyx Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.60 Bn | -29.59 | — | 3.60 Bn |
| 135 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -7.79 | 30.64 | 2.88 Bn |
| 136 | TNGX | Tango Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.57 Bn | -34.90 | 66.37 | 2.56 Bn |
| 137 | IDYA | IDEAYA Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.54 Bn | -16.07 | 15.11 | 2.71 Bn |
| 138 | ABCL | AbCellera Biologics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.37 Bn | -20.49 | 50.98 | 3.37 Bn |
| 139 | DYN | Dyne Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.18 Bn | -6.15 | — | 3.18 Bn |
| 140 | ARQT | Arcutis Biotherapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.11 Bn | 109.08 | 6.70 | 2.87 Bn |
| 141 | CLDX | Celldex Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.02 Bn | -9.83 | 19,122.53 | 3.02 Bn |
| 142 | MBX | MBX Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.99 Bn | -28.68 | — | 2.99 Bn |
| 143 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.96 Bn | -10.96 | 593.06 | 2.44 Bn |
| 144 | IRON | Disc Medicine, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.95 Bn | -14.67 | — | 2.95 Bn |
| 145 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.93 Bn | -8.57 | 79.61 | 2.48 Bn |
| 146 | FUL | Fuller H B Co | secondary | M-03 | Chemicals | MG-01 | 2.82 Bn | 19.08 | 0.80 | 2.70 Bn |
| 147 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.80 Bn | -14.90 | 6.24 | 2.10 Bn |
| 148 | WTTR | Select Water Solutions, Inc. | secondary | E-10 | Oilfield Services and Equipment | EG-04 | 2.78 Bn | 86.42 | 1.94 | 2.74 Bn |
| 149 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | -81.36 | — | 2.64 Bn |
| 150 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | 4.54 | 0.06 | -3.19 Bn |
| 151 | OCUL | Ocular Therapeutix, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.58 Bn | -8.52 | 49.52 | 2.58 Bn |
| 152 | AXGN | Axogen, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.51 Bn | -169.96 | 10.01 | 2.40 Bn |
| 153 | BEIGF | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 154 | VERA | Vera Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -6.10 | — | 2.44 Bn |
| 155 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -28.71 | 3.10 | 2.07 Bn |
| 156 | NKTR | Nektar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.41 Bn | -20.29 | 44.17 | 1.73 Bn |
| 157 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.41 Bn | 13.50 | 2.51 | 1.60 Bn |
| 158 | VRDN | Viridian Therapeutics, Inc.\DE | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.40 Bn | -5.99 | 33.69 | 2.40 Bn |
| 159 | SRPT | Sarepta Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.33 Bn | -16.97 | 1.18 | 1.53 Bn |
| 160 | XTLB | Xtl Biopharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -2,975.41 | — | 2.29 Bn |
| 161 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -5.95 | 4.28 | 1.94 Bn |
| 162 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.28 Bn | -21.11 | 13.44 | 2.28 Bn |
| 163 | CC | Chemours Co | secondary | M-01 | Chemicals | MG-01 | 2.28 Bn | -7.47 | 0.39 | 1.61 Bn |
| 164 | URGN | UroGen Pharma Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.27 Bn | -36.49 | 12.04 | 2.16 Bn |
| 165 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.27 Bn | -3.87 | — | 2.00 Bn |
| 166 | PHVS | Pharvaris N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.23 Bn | -11.24 | — | 1.86 Bn |
| 167 | MTX | Minerals Technologies Inc | secondary | M-16 | Metals and Mining | MG-02 | 2.16 Bn | -7.89 | 1.00 | 1.81 Bn |
| 168 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.15 Bn | 12.91 | 4.19 | 2.01 Bn |
| 169 | GMAB | Genmab A/S | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.14 Bn | 0.17 | 0.34 | 0.63 Bn |
| 170 | KOD | Kodiak Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.12 Bn | -8.78 | — | 2.12 Bn |
| 171 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.11 Bn | 6.70 | 6.76 | 1.66 Bn |
| 172 | AGIO | Agios Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.06 Bn | -5.01 | 20.99 | 2.06 Bn |
| 173 | RAPP | Rapport Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.06 Bn | -15.00 | 102.87 | 2.06 Bn |
| 174 | CMPS | COMPASS Pathways plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.04 Bn | -5.16 | — | 2.04 Bn |
| 175 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.03 Bn | -4.89 | 2,033.16 | 2.03 Bn |
| 176 | OLN | OLIN Corp | secondary | M-01 | Chemicals | MG-01 | 1.99 Bn | -10.13 | 0.30 | 1.82 Bn |
| 177 | ZYME | Zymeworks Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.98 Bn | -13.21 | 53.36 | 1.71 Bn |
| 178 | STOK | Stoke Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.98 Bn | -9.53 | 71.80 | 1.69 Bn |
| 179 | XNCR | Xencor Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.89 Bn | -11.60 | 18.04 | 1.52 Bn |
| 180 | VIR | Vir Biotechnology, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.82 Bn | -7.23 | 6.00 | 1.82 Bn |
| 181 | SNDX | Syndax Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.77 Bn | -9.74 | 7.00 | 1.22 Bn |
| 182 | INBX | Inhibrx Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.76 Bn | -13.23 | 1,357.12 | 1.76 Bn |
| 183 | IMCR | Immunocore Holdings plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.75 Bn | -96.63 | 4.06 | 0.87 Bn |
| 184 | GLPGF | Lakefront Biotherapeutics NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.73 Bn | 0.00 | 1.50 | 1.73 Bn |
| 185 | RXRX | Recursion Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.72 Bn | -3.31 | 31.30 | 1.17 Bn |
| 186 | SEPN | Septerna, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.71 Bn | -122.77 | 17.33 | 1.71 Bn |
| 187 | GHRS | GH Research PLC | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.68 Bn | -26.90 | — | 1.31 Bn |
| 188 | DMRA | Damora Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | -6.19 | — | 1.09 Bn |
| 189 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | -6.57 | 3.93 | 0.91 Bn |
| 190 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | -194.01 | 943.71 | 1.62 Bn |
| 191 | ANAB | Anaptysbio, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.60 Bn | -67.19 | 8.06 | 1.32 Bn |
| 192 | BCAX | Bicara Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.60 Bn | -8.63 | — | 1.60 Bn |
| 193 | ATAI | AtaiBeckley Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.59 Bn | -10.33 | 523.75 | 1.59 Bn |
| 194 | FBRX | Forte Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.58 Bn | -20.71 | — | 1.23 Bn |
| 195 | BAK | Braskem Sa | secondary | M-01 | Chemicals | MG-01 | 1.57 Bn | -0.82 | 0.11 | -0.63 Bn |
| 196 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 20.12 | 1.26 Bn |
| 197 | PAHC | Phibro Animal Health Corp | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 14.92 | 0.98 | 1.41 Bn |
| 198 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | -3.17 | 2.04 | 1.17 Bn |
| 199 | ANRO | Alto Neuroscience, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -17.48 | — | 1.46 Bn |
| 200 | MAZE | Maze Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.45 Bn | -13.63 | 72.27 | 1.45 Bn |
| 201 | GLUE | Monte Rosa Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.44 Bn | -9.37 | 50.20 | 0.81 Bn |
| 202 | SDGR | Schrodinger, Inc. | secondary | T-27 | Vertical Software | TG-05 | 1.44 Bn | -26.48 | 5.56 | 1.03 Bn |
| 203 | TYRA | Tyra Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -9.65 | — | 1.43 Bn |
| 204 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -8.67 | — | 1.42 Bn |
| 205 | REPL | Replimune Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.40 Bn | -4.73 | — | 1.40 Bn |
| 206 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.40 Bn | 82.16 | 36.50 | 1.40 Bn |
| 207 | SVRA | Savara Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.37 Bn | -9.82 | — | 1.37 Bn |
| 208 | ABSI | Absci Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.37 Bn | -11.30 | 876.13 | 1.17 Bn |
| 209 | ORIC | Oric Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.36 Bn | -8.64 | — | 1.36 Bn |
| 210 | CGEM | Cullinan Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.33 Bn | -6.49 | — | 1.33 Bn |
| 211 | VOR | Vor Biopharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.27 Bn | -1.37 | — | 1.27 Bn |
| 212 | ALMS | Alumis Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.25 Bn | -5.18 | 150.67 | 0.75 Bn |
| 213 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -25.77 | — | 1.02 Bn |
| 214 | MNKD | Mannkind Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.22 Bn | -28.00 | 3.10 | 1.11 Bn |
| 215 | JANX | Janux Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.22 Bn | -11.87 | 50.76 | 1.22 Bn |
| 216 | JBIO | Jade Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.16 Bn | -7.56 | — | 1.16 Bn |
| 217 | CLYM | Climb Bio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.14 Bn | -19.84 | — | 1.14 Bn |
| 218 | ECVT | Ecovyst Inc. | secondary | M-01 | Chemicals | MG-01 | 1.13 Bn | -18.24 | 1.30 | 1.04 Bn |
| 219 | IMTX | Immatics N.V. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.12 Bn | -4.64 | 22.98 | 0.66 Bn |
| 220 | ABUS | Arbutus Biopharma Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 6.67 | 5.60 | 0.92 Bn |
| 221 | MLTX | MoonLake Immunotherapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | -3.82 | — | 0.48 Bn |
| 222 | ACDC | ProFrac Holding Corp. | secondary | E-10 | Oilfield Services and Equipment | EG-04 | 1.00 Bn | -2.44 | 0.56 | 0.98 Bn |
| 223 | OKYO | OKYO Pharma Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.99 Bn | -118.02 | — | 0.99 Bn |
| 224 | WVE | Wave Life Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -4.81 | 14.90 | 0.61 Bn |
| 225 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -70.03 | — | 0.92 Bn |
| 226 | ARDX | Ardelyx, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -17.06 | 2.11 | 0.67 Bn |
| 227 | GERN | Geron Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -13.99 | 3.86 | 0.64 Bn |
| 228 | KODK | Eastman Kodak Co | secondary | I-30 | Business Services | IG-06 | 0.89 Bn | -13.41 | 0.78 | 0.57 Bn |
| 229 | TBPH | Theravance Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.88 Bn | 20.84 | 8.45 | 0.49 Bn |
| 230 | RIGL | Rigel Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.88 Bn | 2.72 | 3.17 | 0.78 Bn |
| 231 | ANNX | Annexon, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.87 Bn | -4.26 | — | 0.87 Bn |
| 232 | DQ | Daqo New Energy Corp. | secondary | M-01 | Chemicals | MG-01 | 0.82 Bn | -4.27 | 1.47 | 0.01 Bn |
| 233 | STTK | Shattuck Labs, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.82 Bn | -15.12 | 816.31 | 0.82 Bn |
| 234 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.91 | 9.10 | 0.66 Bn |
| 235 | AVTX | Avalo Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -7.93 | — | 0.80 Bn |
| 236 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.79 Bn | -9.89 | 95.78 | 0.79 Bn |
| 237 | CTMX | CytomX Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.77 Bn | -10.21 | 42.29 | 0.44 Bn |
| 238 | PHAR | Pharming Group N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.76 Bn | -122.18 | 2.28 | 0.60 Bn |
| 239 | ZURA | Zura Bio Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.72 Bn | -6.21 | — | 0.72 Bn |
| 240 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | 12.24 | 5.24 | 0.49 Bn |
| 241 | AURA | Aura Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.68 Bn | -6.22 | — | 0.61 Bn |
| 242 | IRWD | Ironwood Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.67 Bn | 3.03 | 1.72 | 0.59 Bn |
| 243 | SLN | Silence Therapeutics plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -16.42 | 1,038.05 | 0.57 Bn |
| 244 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.07 | 1.70 | 0.38 Bn |
| 245 | ASMB | Assembly Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | 502.49 | 8.35 | 0.30 Bn |
| 246 | ALT | Altimmune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.62 Bn | -8.43 | — | 0.62 Bn |
| 247 | CBIO | Crescent Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -3.75 | 589.05 | 0.44 Bn |
| 248 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -340,055.90 | — | 0.60 Bn |
| 249 | LPTH | Lightpath Technologies Inc | secondary | I-02 | Aerospace and Defense | IG-01 | 0.60 Bn | -69.40 | 9.49 | 0.54 Bn |
| 250 | TECX | Tectonic Therapeutic, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.58 Bn | -6.72 | — | 0.58 Bn |
| 251 | VALN | Valneva SE | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -9.79 | 3.43 | 0.43 Bn |
| 252 | SGMT | Sagimet Biosciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -11.82 | — | 0.57 Bn |
| 253 | ARVN | Arvinas, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | 61.21 | 1.80 | 0.00 Bn |
| 254 | CTNM | Contineum Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -9.40 | — | 0.57 Bn |
| 255 | FLGT | Fulgent Genetics, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.56 Bn | -6.62 | 2.32 | 0.30 Bn |
| 256 | BBOT | BridgeBio Oncology Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -2.72 | — | 0.32 Bn |
| 257 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -15.37 | 334.91 | 0.41 Bn |
| 258 | OABI | OmniAb, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -11.67 | 13.43 | 0.46 Bn |
| 259 | IMUX | Immunic, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -4.48 | — | 0.52 Bn |
| 260 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -7.41 | 22.27 | 0.22 Bn |
| 261 | PRTA | Prothena Corp Public Ltd Co | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.48 Bn | -11.04 | 8.89 | 0.20 Bn |
| 262 | CNTN | Canton Strategic Holdings, Inc. | secondary | T-58 | Fintech | TG-09 | 0.48 Bn | -5.85 | 330.55 | 0.48 Bn |
| 263 | KMDA | Kamada Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | 15.22 | 2.47 | 0.40 Bn |
| 264 | NEUP | Neuphoria Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -19.72 | — | 0.45 Bn |
| 265 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -10.27 | 78.36 | 0.23 Bn |
| 266 | RLMD | Relmada Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -7.55 | — | 0.46 Bn |
| 267 | LXFR | Luxfer Holdings Plc | secondary | I-09 | Machinery | IG-02 | 0.46 Bn | 57.77 | 1.27 | 0.45 Bn |
| 268 | PBYI | Puma Biotechnology, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | 15.39 | 1.99 | 0.37 Bn |
| 269 | CYPH | Cypherpunk Technologies Inc. | secondary | T-58 | Fintech | TG-09 | 0.45 Bn | 7.62 | — | 0.45 Bn |
| 270 | DRUG | Bright Minds Biosciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -15.52 | — | 0.45 Bn |
| 271 | CCCC | C4 Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.44 | 12.85 | 0.20 Bn |
| 272 | AVIR | Atea Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -3.09 | — | 0.42 Bn |
| 273 | RZLT | Rezolute, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -5.18 | — | 0.42 Bn |
| 274 | ARCT | Arcturus Therapeutics Holdings Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -4.40 | 14.27 | 0.23 Bn |
| 275 | CMPX | Compass Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -5.07 | — | 0.41 Bn |
| 276 | BIOA | BioAge Labs, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -4.36 | 39.58 | 0.41 Bn |
| 277 | LRMR | Larimar Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.40 Bn | -2.28 | — | 0.24 Bn |
| 278 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -4.14 | 39.23 | 0.19 Bn |
| 279 | ENTA | Enanta Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.38 Bn | -6.09 | 5.89 | 0.19 Bn |
| 280 | HMDCF | HUTCHMED (China) Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.38 Bn | — | — | 0.39 Bn |
| 281 | EYPT | EyePoint, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.37 Bn | -1.21 | 134.36 | 0.19 Bn |
| 282 | OFIX | Orthofix Medical Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.36 Bn | -8.34 | 0.44 | 0.26 Bn |
| 283 | CATX | Perspective Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.36 Bn | -3.02 | — | 0.36 Bn |
| 284 | OCGN | Ocugen, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.36 Bn | -4.39 | 78.38 | 0.26 Bn |
| 285 | WHWK | Whitehawk Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.35 Bn | -4.36 | — | 0.35 Bn |
| 286 | FHTX | Foghorn Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -5.03 | 9.00 | 0.26 Bn |
| 287 | UPB | Upstream Bio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -2.03 | 102.81 | 0.32 Bn |
| 288 | ELDN | Eledon Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -3.86 | — | 0.32 Bn |
| 289 | EPRX | Eupraxia Pharmaceuticals Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -6.37 | — | 0.32 Bn |
| 290 | NNDM | Nano Dimension Ltd. | secondary | I-12 | Machinery | IG-02 | 0.32 Bn | -2.17 | 2.61 | -0.03 Bn |
| 291 | CLLS | Cellectis S.A. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -7.50 | 5.28 | 0.14 Bn |
| 292 | STRO | Sutro Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -2.69 | 3.39 | 0.14 Bn |
| 293 | TRDA | Entrada Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -1.82 | 64.42 | 0.30 Bn |
| 294 | AGEN | Agenus Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | 3.08 | 2.13 | 0.28 Bn |
| 295 | EQ | Equillium, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -15.70 | — | 0.28 Bn |
| 296 | BCYC | Bicycle Therapeutics Plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -1.46 | 4.56 | 0.28 Bn |
| 297 | TLSI | TriSalus Life Sciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | -4.74 | 6.17 | 0.23 Bn |
| 298 | ACIU | AC Immune SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -5.13 | 12.56 | 0.28 Bn |
| 299 | SABS | SAB Biotherapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -4.04 | — | 0.28 Bn |
| 300 | GALT | Galectin Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -9.52 | — | 0.27 Bn |